Transcat, Inc. (NASDAQ:TRNS) Receives Consensus Rating of “Hold” from Brokerages

Shares of Transcat, Inc. (NASDAQ:TRNS) have been assigned a consensus rating of “Hold” from the five ratings firms that are presently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $111.50.

A number of research firms have issued reports on TRNS. Oppenheimer downgraded shares of Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. HC Wainwright dropped their price target on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. Craig Hallum lifted their price objective on Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. StockNews.com lowered Transcat from a “hold” rating to a “sell” rating in a research report on Wednesday, February 5th. Finally, Northland Securities reaffirmed a “market perform” rating and set a $85.00 price target (down from $110.00) on shares of Transcat in a research note on Wednesday, January 29th.

Insiders Place Their Bets

In related news, Director Craig D. Cairns purchased 1,200 shares of the firm’s stock in a transaction dated Friday, January 31st. The stock was bought at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the purchase, the director now owns 1,910 shares in the company, valued at $147,108.20. The trade was a 169.01 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 2.30% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Neuberger Berman Group LLC boosted its position in Transcat by 1.8% during the fourth quarter. Neuberger Berman Group LLC now owns 873,985 shares of the scientific and technical instruments company’s stock worth $92,415,000 after purchasing an additional 15,723 shares during the period. Champlain Investment Partners LLC boosted its holdings in shares of Transcat by 35.7% during the 4th quarter. Champlain Investment Partners LLC now owns 555,650 shares of the scientific and technical instruments company’s stock worth $58,754,000 after buying an additional 146,150 shares during the period. T. Rowe Price Investment Management Inc. boosted its holdings in shares of Transcat by 178.0% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 518,597 shares of the scientific and technical instruments company’s stock worth $54,837,000 after buying an additional 332,064 shares during the period. Geode Capital Management LLC raised its holdings in Transcat by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 219,354 shares of the scientific and technical instruments company’s stock worth $23,200,000 after acquiring an additional 1,881 shares during the period. Finally, Dimensional Fund Advisors LP lifted its position in Transcat by 5.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 209,200 shares of the scientific and technical instruments company’s stock worth $22,121,000 after acquiring an additional 10,186 shares during the last quarter. 98.34% of the stock is owned by institutional investors.

Transcat Stock Down 1.3 %

NASDAQ:TRNS opened at $69.07 on Wednesday. The business’s fifty day moving average price is $82.92 and its 200 day moving average price is $102.43. The firm has a market capitalization of $642.97 million, a price-to-earnings ratio of 37.34 and a beta of 0.66. The company has a current ratio of 2.42, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14. Transcat has a 1-year low of $67.56 and a 1-year high of $147.12.

Transcat (NASDAQ:TRNS) last issued its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same period in the prior year, the business posted $0.56 EPS. On average, sell-side analysts forecast that Transcat will post 2.3 earnings per share for the current fiscal year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.